Diabetes; Infectious Diseases; Pharmacology; Diseases and Conditions; Personalized Medicine; Today's Healthcare; Patient Education and Counseling; Immune System

The Evolving Threat of ‘Superbug’ E. coli in Diabetic Foot Infections: A Genomic Revolution in Treatment Over 37 million Americans live with diabetes, and a staggering 15% will develop a foot ulcer during their lifetime. But a silent, and increasingly complex, threat lurks within these wounds: E. coli. Recent global genomic research, spearheaded by King’s … Read more